324 related articles for article (PubMed ID: 30842242)
1. Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.
Creelan BC; Ahmad MU; Kaszuba FJ; Khalil FK; Welsh AW; Ozdemirli M; Grant NN; Subramaniam DS
Oncologist; 2019 Jun; 24(6):829-835. PubMed ID: 30842242
[TBL] [Abstract][Full Text] [Related]
2. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
[TBL] [Abstract][Full Text] [Related]
3. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
[TBL] [Abstract][Full Text] [Related]
4. Systemic bevacizumab for recurrent respiratory papillomatosis.
Baday YI; Ongkasuwan J; Venkatramani R
Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110352. PubMed ID: 32906078
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of juvenile-onset and adult-onset recurrent respiratory papillomatosis].
Shiobara Y; Goto H; Hoshino M; Tsukahara T; Yamaguchi N; Ito M; Nozawa A; Tsukiji J; Ishigatsubo Y; Kaneko T
Nihon Kokyuki Gakkai Zasshi; 2011 Sep; 49(9):667-73. PubMed ID: 22073613
[TBL] [Abstract][Full Text] [Related]
6. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
7. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.
Wiatrak BJ; Wiatrak DW; Broker TR; Lewis L
Laryngoscope; 2004 Nov; 114(11 Pt 2 Suppl 104):1-23. PubMed ID: 15514560
[TBL] [Abstract][Full Text] [Related]
8. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
9. Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial.
Massarelli E; William W; Johnson F; Kies M; Ferrarotto R; Guo M; Feng L; Lee JJ; Tran H; Kim YU; Haymaker C; Bernatchez C; Curran M; Zecchini Barrese T; Rodriguez Canales J; Wistuba I; Li L; Wang J; van der Burg SH; Melief CJ; Glisson B
JAMA Oncol; 2019 Jan; 5(1):67-73. PubMed ID: 30267032
[TBL] [Abstract][Full Text] [Related]
10. Infantile recurrent respiratory papillomatosis: review of adjuvant therapies.
Patel A; Orban N
J Laryngol Otol; 2021 Nov; 135(11):958-963. PubMed ID: 34470689
[TBL] [Abstract][Full Text] [Related]
11. Is recurrent respiratory papillomatosis a manageable or curable disease?
Kim HT; Baizhumanova AS
Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
[TBL] [Abstract][Full Text] [Related]
12. Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report.
Merhi M; Raza A; Inchakalody VP; Nashwan AJJ; Allahverdi N; Krishnankutty R; Uddin S; Zar Gul AR; Al Homsi MU; Dermime S
Front Immunol; 2018; 9():1769. PubMed ID: 30108590
[TBL] [Abstract][Full Text] [Related]
13. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus laryngeal tracheal papillomatosis.
Alfano DM
J Pediatr Health Care; 2014; 28(5):451-5. PubMed ID: 24882788
[No Abstract] [Full Text] [Related]
16. Clinical and treatment course of lung carcinoma from adult-onset recurrent respiratory papillomatosis with lung involvement: A case report.
Cardoso Figueiredo M; Chantre-Justino M; Latini Ruback R; Pires de Mello P; Alves G; Helena Ornellas M
Oral Oncol; 2021 Oct; 121():105398. PubMed ID: 34167900
[TBL] [Abstract][Full Text] [Related]
17. Recurrent respiratory papillomatosis: update 2018.
Derkay CS; Bluher AE
Curr Opin Otolaryngol Head Neck Surg; 2018 Dec; 26(6):421-425. PubMed ID: 30300210
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
19. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.
Kashima HK; Shah F; Lyles A; Glackin R; Muhammad N; Turner L; Van Zandt S; Whitt S; Shah K
Laryngoscope; 1992 Jan; 102(1):9-13. PubMed ID: 1309932
[TBL] [Abstract][Full Text] [Related]
20. Recurrent respiratory papillomatosis: A state-of-the-art review.
Fortes HR; von Ranke FM; Escuissato DL; Araujo Neto CA; Zanetti G; Hochhegger B; Souza CA; Marchiori E
Respir Med; 2017 May; 126():116-121. PubMed ID: 28427542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
